Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorXia, Ying-
dc.contributor.authorMaruff, Paul-
dc.contributor.authorDoré, Vincent-
dc.contributor.authorBourgeat, Pierrick-
dc.contributor.authorLaws, Simon M-
dc.contributor.authorFowler, Christopher-
dc.contributor.authorRainey-Smith, Stephanie R-
dc.contributor.authorMartins, Ralph N-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorCoulson, Elizabeth J-
dc.contributor.authorFripp, Jurgen-
dc.date2023-
dc.date.accessioned2023-10-11T06:21:16Z-
dc.date.available2023-10-11T06:21:16Z-
dc.date.issued2023-09-11-
dc.identifier.citationNeurobiology of Aging 2023-09-11; 132en_US
dc.identifier.issn1558-1497-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33950-
dc.description.abstractDysfunction of the cholinergic basal forebrain (BF) system and amyloid-β (Aβ) deposition are early pathological features in Alzheimer's disease (AD). However, their association in early AD is not well-established. This study investigated the nature and magnitude of volume loss in the BF, over an extended period, in 516 older adults who completed Aβ-PET and serial magnetic resonance imaging scans. Individuals were grouped at baseline according to the presence of cognitive impairment (CU, CI) and Aβ status (Aβ-, Aβ+). Longitudinal volumetric changes in the BF and hippocampus were assessed across groups. The results indicated that high Aβ levels correlated with faster volume loss in the BF and hippocampus, and the effect of Aβ varied within BF subregions. Compared to CU Aβ+ individuals, Aβ-related loss among CI Aβ+ adults was much greater in the predominantly cholinergic subregion of Ch4p, whereas no difference was observed for the Ch1/Ch2 region. The findings support early and substantial vulnerability of the BF and further reveal distinctive degeneration of BF subregions during early AD.en_US
dc.language.isoeng-
dc.subjectAlzheimer’s diseaseen_US
dc.subjectAmyloid-βen_US
dc.subjectBasal forebrainen_US
dc.subjectLongitudinalen_US
dc.subjectMagnetic resonance imagingen_US
dc.titleLongitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleNeurobiology of Agingen_US
dc.identifier.affiliationThe Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Queensland, Australia.en_US
dc.identifier.affiliationCogstate Ltd, Melbourne, Victoria, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationNuclear Medicine and Centre for PET, Austin Health, Melbourne, Victoria, Australia; The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Melbourne, Victoria, Australia.en_US
dc.identifier.affiliationThe Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Queensland, Australia.en_US
dc.identifier.affiliationCollaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia; Centre for Precision Health, Edith Cowan University, Joondalup, Western Australia, Australia; Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.en_US
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.en_US
dc.identifier.affiliationCentre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia; Australian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia; School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia.en_US
dc.identifier.affiliationAustralian Alzheimer's Research Foundation, Sarich Neuroscience Research Institute, Nedlands, Western Australia, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia; Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.en_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.affiliationQueensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia.en_US
dc.identifier.doi10.1016/j.neurobiolaging.2023.09.002en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37801885-
dc.description.volume132-
dc.description.startpage120-
dc.description.endpage130-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.